July 30, 2014 5:18 AM ET

Pharmaceuticals

Company Overview of Anosys Inc.

Company Overview

As of December 31, 2005, Anosys Inc. was acquired by Chromos Molecular Systems Inc. Anosys Inc. develops therapeutic vaccines for the treatment of cancer, infectious, and autoimmune diseases. Its products are based on exosomes, which are small vesicles that contain components required to activate the innate and cellular immune responses necessary to fight disease. The company is based in Menlo Park, California and has an additional office in Evry, France.

1014 Hamilton Court

Menlo Park, CA 94025

United States

Phone:

650-321-9500

Fax:

650-324-4733

Key Executives for Anosys Inc.

Anosys Inc. does not have any Key Executives recorded.

Similar Private Companies By Industry

Company Name Region
Barr Laboratories, Inc. United States
Amarin Pharmaceuticals, Inc. United States
Compound Healthcare, Inc. United States
Wincott & Associates, LLC United States
Desert West Marketing Inc United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Anosys Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.